• 8 Hits
  • Search Condition : Filter (MeSH = Cystadenocarcinoma, Serous / pathology)
Species Resource Title
Human and Animal Cells JHOS-2(RCB1521) TIMP-2 regulates proliferation, invasion and STAT3-mediated cancer stem cell-dependent chemoresistance in ovarian cancer cells.
Human and Animal Cells OVK18(RCB1903) , JHOC-5(RCB1520) Identification of ovarian high-grade serous carcinoma cell lines that show estrogen-sensitive growth as xenografts in immunocompromised mice.
Human and Animal Cells NIH:OVCAR-3(RCB2135) ZNF671 DNA methylation as a molecular predictor for the early recurrence of serous ovarian cancer.
Human and Animal Cells JHOS-2(RCB1521) , JHOS-3(RCB1546) , JHOS-4(RCB1678) Histone methyltransferase SMYD2 selective inhibitor LLY-507 in combination with poly ADP ribose polymerase inhibitor has therapeutic potential against high-grade serous ovarian carcinomas.
Human and Animal Cells JHOC-5(RCB1520) Low uptake of fluorodeoxyglucose in positron emission tomography/computed tomography in ovarian clear cell carcinoma may reflect glutaminolysis of its cancer stem cell-like properties.
Human and Animal Cells JHOC-5(RCB1520) , JHOC-8(RCB1723) Epigenetic modification is involved in aberrant expression of class III beta-tubulin, TUBB3, in ovarian cancer cells.
Human and Animal Cells Survivin, bcl-2 and matrix metalloproteinase-2 enhance progression of clear cell- and serous-type ovarian carcinomas.
Human and Animal Cells NIH:OVCAR-3(RCB2135) Claudin-4: a potential therapeutic target in chemotherapy-resistant ovarian cancer.